IRIS
CAPURSO, GABRIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.994
EU - Europa 7.776
NA - Nord America 6.601
SA - Sud America 1.511
Continente sconosciuto - Info sul continente non disponibili 597
AF - Africa 132
OC - Oceania 9
Totale 24.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.202
RU - Federazione Russa 4.837
SG - Singapore 3.064
CN - Cina 2.485
BR - Brasile 1.248
IT - Italia 984
HK - Hong Kong 932
VN - Vietnam 615
FR - Francia 404
SE - Svezia 372
DE - Germania 303
BD - Bangladesh 292
GB - Regno Unito 232
CA - Canada 183
IN - India 123
FI - Finlandia 121
AR - Argentina 106
MX - Messico 100
NL - Olanda 100
PL - Polonia 83
AT - Austria 80
ZA - Sudafrica 65
JP - Giappone 60
TR - Turchia 60
ES - Italia 57
IQ - Iraq 53
ID - Indonesia 50
EC - Ecuador 41
MD - Moldavia 33
IE - Irlanda 32
PK - Pakistan 30
UA - Ucraina 27
UZ - Uzbekistan 27
VE - Venezuela 26
JM - Giamaica 24
LT - Lituania 24
CR - Costa Rica 23
CO - Colombia 22
MY - Malesia 20
BE - Belgio 19
PY - Paraguay 19
SA - Arabia Saudita 19
AE - Emirati Arabi Uniti 17
IL - Israele 15
NP - Nepal 15
PH - Filippine 15
RO - Romania 15
UY - Uruguay 14
CL - Cile 13
HN - Honduras 13
MA - Marocco 13
BH - Bahrain 12
GT - Guatemala 11
KE - Kenya 11
TT - Trinidad e Tobago 11
TW - Taiwan 11
AU - Australia 9
CH - Svizzera 9
EG - Egitto 9
JO - Giordania 9
NI - Nicaragua 9
OM - Oman 9
TH - Thailandia 9
TN - Tunisia 9
IR - Iran 8
PE - Perù 8
BO - Bolivia 7
PT - Portogallo 7
SV - El Salvador 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
AL - Albania 5
HU - Ungheria 5
LB - Libano 5
PS - Palestinian Territory 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
GE - Georgia 4
GY - Guiana 4
KR - Corea 4
KZ - Kazakistan 4
PR - Porto Rico 4
AM - Armenia 3
AZ - Azerbaigian 3
CI - Costa d'Avorio 3
CY - Cipro 3
ET - Etiopia 3
GR - Grecia 3
HR - Croazia 3
KW - Kuwait 3
PA - Panama 3
SR - Suriname 3
AO - Angola 2
BG - Bulgaria 2
BY - Bielorussia 2
KG - Kirghizistan 2
KH - Cambogia 2
ML - Mali 2
NG - Nigeria 2
SN - Senegal 2
Totale 23.998
Salva come PNG Salva come JPEG
Città #
Singapore 1.521
Moscow 1.033
Dallas 946
Hong Kong 917
Ashburn 866
San Jose 849
Shanghai 449
Council Bluffs 431
Hefei 349
Lauterbourg 302
Beijing 299
New York 252
Ho Chi Minh City 215
Milan 206
Los Angeles 168
Santa Clara 152
Hanoi 148
São Paulo 130
Rome 102
Nuremberg 94
Boardman 87
Munich 87
Lawrence 86
Princeton 86
Orem 78
Warsaw 69
Montreal 58
Brooklyn 51
Tokyo 51
Chicago 49
Johannesburg 49
Phoenix 49
Atlanta 48
Turku 48
Helsinki 47
Rio de Janeiro 46
Guangzhou 41
London 39
Chennai 38
Frankfurt am Main 38
Stockholm 38
Vienna 38
Denver 36
Mexico City 35
Washington 35
Amsterdam 34
Houston 34
Manchester 33
Poplar 33
Toronto 32
Dublin 31
Seattle 31
Buffalo 30
Las Vegas 28
Brescia 27
Belo Horizonte 26
Boston 26
Lappeenranta 26
Da Nang 25
Bologna 24
Brasília 24
Tashkent 24
Ankara 23
Naples 22
San Francisco 22
Cesano Boscone 21
Columbus 21
Curitiba 21
Barnet 20
Shenzhen 20
Miami 19
Mumbai 19
The Dalles 19
Assago 18
Hangzhou 18
Majano 18
Omaha 18
Paris 18
Haiphong 17
Porto Alegre 17
Campinas 16
Minneapolis 16
San José 16
Tianjin 16
Dhaka 15
Palermo 15
Philadelphia 15
Salvador 15
Bergamo 14
Brussels 14
Jakarta 14
Jiaxing 14
Kingston 14
Baghdad 13
Biên Hòa 13
New Delhi 13
Verona 13
Goiânia 12
Guayaquil 12
Jacksonville 12
Totale 11.877
Salva come PNG Salva come JPEG
Nome #
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 194
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 182
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 181
Asymptomatic Chronic Elevation of Serum Pancreatic Enzymes: How to Deal with It? 177
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 176
DIAGNOSTIC ACCURACY OF ENDOSCOPIC ULTRASOUND-FINE NEEDLE ASPIRATION (EUS-FNA) IN THE EVALUATION OF PANCREATIC NEUROENDOCRINE NEOPLASMS (PNEN) GRADING 160
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 158
Genetic and non-genetic risk factors for early-onset pancreatic cancer 151
International external validation of a stratification tool to identify branch-duct intraductal papillary mucinous neoplasms at lowest risk of progression 150
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 149
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 148
European evidence-based guidelines on pancreatic cystic neoplasms 146
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 146
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 140
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 140
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 139
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 138
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma 135
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 134
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 134
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 128
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 128
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 128
Needle-Tract Seeding of Pancreatic Cancer after EUS-FNA: A Systematic Review of Case Reports and Discussion of Management 125
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 124
Association of Genetic Variants Affecting microRNAs and Pancreatic Cancer Risk 123
Associations between pancreatic expression quantitative traits and risk of pancreatic ductal adenocarcinoma 123
Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study 122
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 122
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 122
The prevalence of pancreatic cystic lesions in patients with liver cirrhosis is double that in controls 121
Common variability in oestrogen-related genes and pancreatic ductal adenocarcinoma risk in women. 119
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 119
Urgent manifestations of immunoglobulin G4-related disease 118
Intraductal Papillary Mucinous Neoplasms in High-Risk Individuals: Incidence, Growth Rate, and Malignancy Risk 117
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 115
Multicentric Italian survey on daily practice for autoimmune pancreatitis: Clinical data, diagnosis, treatment, and evolution toward pancreatic insufficiency 115
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 114
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 111
Managing complications of chronic pancreatitis: a guide for the gastroenterologist 110
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 110
Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study 109
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 109
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 108
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 108
Early onset pancreatic cancer. Risk factors, presentation and outcome 108
Differential EUS findings in focal type 1 autoimmune pancreatitis and pancreatic cancer: A proof-of-concept study 107
Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification 106
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 105
Systematic review and meta-analysis: Prevalence of incidentally detected pancreatic cystic lesions in asymptomatic individuals 105
EUS-guided gallbladder drainage and subsequent peroral endoscopic cholecystolithotomy: A tool to reduce chemotherapy discontinuation in neoplastic patients? 103
Chronic use of statins and acetylsalicylic acid and incidence of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: A multicenter, prospective, cohort study 103
Italian Chronic Pancreatitis Registry (ITARECIPE): Protocol for a nationwide cohort study 103
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 102
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 101
Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis 101
Efficacy of endoscopic ultrasound-guided ablation with the hybridtherm probe in locally advanced or borderline resectable pancreatic cancer: A phase ii randomized controlled trial 101
ENDOSCOPIC ULTRASOUND (EUS)-GUIDED RADIOFREQUENCY ABLATION (RFA) OF A SYMPTOMATIC PANCREATIC INSULINOMA 100
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features 99
4. Smoking, alcohol and family history of cancer as risk factors for small intestinal neuroendocrine tumors: a systematic review and meta-analysis 98
Risk factors for the occurrence of ampullary tumors: A case-control study 97
Alcohol and gastrointestinal cancers 97
The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years’ experience of association studies to understand the genetic architecture of pancreatic cancer 97
Chronic use of statins and aminosalicylic acid and incidence of post-ERCP acute pancreatitis. Preliminary data from the STARK study, a prospective international, multicenter, cohort study 96
ENDOSCOPIC ULTRASOUND-GUIDED HYBRID THERM ABLATION (EUS-HTP) IN PATIENTS (PTS) WITH LOCALLY ADVANCED (LA) PANCREATIC DUCTAL ADENOCARCINOMA (PDAC): A CASE-CONTROL COMPARATIVE SURVIVAL ANALYSIS 96
The EFFect of dietary fat content on the recurrence of pancreaTitis (EFFORT): Protocol of a multicenter randomized controlled trial: Protocol of the EFFORT randomized trial: dietary fat reduction and pancreatitis recurrence 95
Consensus guidelines on severe acute pancreatitis 95
Accuracy of TNM staging system in prognostic siratification of stage IV digestive endocrine tumors 94
The i-EUS consensus on the management of pancreatic fluid collections – Part 1 94
Predicting the need for step-up after EUS-guided drainage of peripancreatic fluid collections, including Quadrant-Necrosis-Infection score validation: A prospective cohort study 94
Italian registry of families at risk of pancreatic cancer: AISP Familial Pancreatic Cancer Study Group 93
Activation of MNK2/eIF4E Pathway by the Splicing Factor SRSF1 Supports Pancreatic Cancer Cell Survival to Genotoxic Stress 93
Hungarian Pancreatic Study Group. Antibiotic therapy in acute pancreatitis: From global overuse to evidence based recommendations 93
Polymorphisms in transcription factor binding sites and enhancer regions and pancreatic ductal adenocarcinoma risk 92
Necrosis volume and Choi criteria predict the response to endoscopic ultrasonography-guided HybridTherm ablation of locally advanced pancreatic cancer 92
ACUTE PANCREATITIS PATIENT REGISTRY TO EXAMINE NOVEL THERAPIES IN CLINICAL EXPERIENCE (APPRENTICE): AN INTERNATIONAL MULTICENTER CONSORTIUM FOR THE STUDY OF ACUTE PANCREATITIS 91
Polygenic and multifactorial scores for pancreatic ductal adenocarcinoma risk prediction 91
The impact of nutritional status on pancreatic cancer therapy 90
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 90
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 90
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 89
EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY 88
A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH 88
Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study 88
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. 88
Acute leukaemia following low dose peptide receptor radionuclide therapy for an intestinal carcinoid 87
Addendum 85
Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma 85
Targeting inflammation to prevent severe acute pancreatitis: NSAIDs are not the holy grail 85
Exocrine pancreatic insufficiency in diabetic patients. prevalence, mechanisms, and treatment 84
High sensitivity of ROSE-supported ERCP-guided brushing for biliary strictures 84
ACCURACY OF THE NOVEL TNM STAGING SYSTEM IN THE PROGNOSTIC STRATIFICATION OF PATIENTS WITH ADVANCED STAGE. IV DIGESTIVE ENDOCRINE. TUMORS 83
Pancreatic Neuroendocrine Neoplasms: Classification and Novel Role of Endoscopic Ultrasound in Diagnosis and Treatment Personalization 83
Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma 83
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals 83
Advanced Digestive Endocrine Tumors: Prognostic Factors Analysis and Patients Stratification According to Metastatic Status 83
Needle-knife fistulotomy vs. standard biliary sphincterotomy for choledocholithiasis: common bile duct stone recurrence and complication rate 82
EUS-guided ablation with the HybridTherm Probe as second-line treatment in patients with locally advanced pancreatic ductal adenocarcinoma: A case-control study 81
Delay in Pancreatic Endoscopic Ultrasound during the COVID-19 Pandemic in a Pancreas/Tertiary Referral Center 81
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer 81
Totale 11.129
Salva come PNG Salva come JPEG
Categoria #
all - tutte 131.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202269 0 0 1 29 9 2 4 3 10 3 2 6
2022/2023642 196 114 47 1 10 80 78 63 30 2 12 9
2023/20241.058 48 36 81 256 70 149 46 111 18 29 65 149
2024/20254.788 512 138 88 131 300 460 557 385 880 600 349 388
2025/202616.469 1.165 1.174 986 1.939 1.208 528 1.518 1.137 4.544 1.122 599 549
2026/20271.509 615 894 0 0 0 0 0 0 0 0 0 0
Totale 24.620